Replies to post #17375 on Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Doesn't this proof trump the black box?

LONG TERM PHASE 3 DATA PUBLISHED IN ARTHRITIS & RHEUMATOLOGY SHOWS LUPKYNIS® (VOCLOSPORIN) PRESERVED KIDNEY FUNCTION UP TO THREE YEARS IN LUPUS NEPHRITIS PATIENTS WITH NO NEW OR UNEXPECTED ADVERSE EVENTS

https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/299/long-term-phase-3-data-published-in-arthritis

*Note- I only mentioned "trump" to keep cervelo calmer
cheers